Skip to content

The Healthcare News Network

Your daily guide to Medicare, insurance, medicines and staying well

Friday, October 23, 2026● Updated 6:00 AM ET
Daily edition

Healthcare news for October 22, 2026

Workers now pay $7,471 a year for family health coverage through their job, up 9% KFF's yearly survey of employer health plans, released today, finds the full cost of a family plan at work averaged $28,303 in 2026, up 5%. Employers still pay most of the bill, but the share taken out of workers' paychecks jumped 9%, more than twice as fast as wages (3.7%) and well ahead of inflation (2.7%). People at small companies are hit hardest: they pay an average of $9,687 a year toward family coverage and face higher deductibles. Many large employers responded by shifting more of the premium onto workers, and relatively few cover GLP-1 weight-loss drugs. If your employer's open enrollment is coming up, compare every plan option, check the deductible and out-of-pocket limit as well as the paycheck deduction, and consider a health savings or flexible spending account to pay for care with pre-tax dollars.

In 30 seconds

Medicare & Seniors

Insurance & ACA

Medicines & FDA

Staying Well

  • Raw-milk cheese recall tied to E. coli outbreak in nine states

    Sierra Nevada Cheese Co. recalled its Graziers raw-milk Monterey Jack, jalapeño jack, medium and sharp cheddar. Thirteen people are sick, more than half of them children 5 and under. FDA gave it its most serious risk rating. Don't eat it; toss it or return it.

    WSAW
  • CDC confirms third U.S. measles death this year

    The national count reached 4,410 cases as of Oct. 15, the most in decades. Pennsylvania, the hardest-hit state, reports 1,286 cases in 42 counties. Two doses of the MMR vaccine are the best protection; check your records if you're unsure.

    Al Jazeera
  • About 4 million tubes of kids' toothpaste recalled

    Seventeen fluoride toothpastes sold under Brush Buddies, EVO and ARU, many with Barbie, Hot Wheels, My Little Pony or Crayola designs, were recalled over manufacturing and testing problems. FDA rates it a lower-risk Class II recall. Check your cabinet against FDA's list.

    NBC Chicago

Policy & Law

Hospitals & Business